Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Mira Pharmaceuticals' drug Ketamir-2 reversed PTSD symptoms in animals and may advance to human trials.

flag MIRA Pharmaceuticals reports that its oral drug candidate Ketamir-2 restored normal behavior in animals within a validated PTSD model, reversing stress-related symptoms like despair and avoidance. flag The results support expanding evaluation into neuropsychiatric disorders, including PTSD, following promising safety data from a Phase 1 trial for neuropathic pain. flag The company plans to explore collaborations with military and government entities to address the significant unmet need for effective PTSD treatments, with a larger follow-on study underway.

3 Articles